Who is Fersat Muhacir?
Dr. Ferşat Muhacir, Fellow of European Board of Ophthalmology (FEBO).
Dr. Ferşat Muhacir was born in Tehran, Iran on April 14, 1967. After completing his primary and secondary education in Ankara, he entered Çukurova University Faculty of Medicine in 1986 and graduated in 1992. In 1993, he started to work as a resident tin 19 Mayıs University Faculty of Medicine Eye Clinic, and after studying at Gazi University Eye Clinic for 6 months in 1996, he received his Eye Diseases and surgery Specialty in 1997.
After his residency, he went to the United States and was an observer at UCSF (University of California San Francisco). In 1998, after working as a specialist in Burdur SSK hospital for a short time, he was appointed as an Ophthalmologist at Bucak State Hospital. In 2002, he went to the Netherlands and Austria and had the opportunity to work on modern cataract surgery.
Special Interests and Fields of Work
Trifocal (Smart), EDOF and Toric (Astigmatism Correcting) Intraocular Lenses
The most up-to-date method of getting rid of far, near and astigmatism glasses
Refractive vision poblems in Children and Their Treatment
Vision Defects in Children and Their Treatment
Cataracts are the most common cause of decreased vision and are treated with surgery.
Laser Treatment in Eye Pressure (SLT)
Can replace eye drops or surgical procedures, It takes a short time, is painless and has no serious side effects.
Xen Stent Application in Eye Pressure Treatment
A current and effective intervention that can replace large incision glaucoma surgery
AutoGraft Treatment for Pterygium
With competent hands and a good surgery, it is possible to achieve a lifetime of comfort without recurrance.
Diabetes related eye diseases
Diagnosis and treatment at the “EARLY” stage is very important to prevent eye problems due to diabetes.
Intraocular Needle Application (Intravitreal Injection)
It is the most current treatment method of age-related yellow spot disease and macular edema.
Age-Related Yellow Spot Disease (Macular Degeneration)
In the wet type, the treatment is intraocular drug injection, while in the dry type, there is still no effective treatment.